Patients with high-risk acute promyelocytic leukemia need maintenance therapy for one year - the CONS
Not available.
Saved in:
| Main Author: | Harry J. Iland |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-04-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patients with high-risk acute promyelocytic leukemia need maintenance therapy for one year - the PROS
by: Martin S. Tallman
Published: (2025-04-01) -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
by: Francesco Lococo, et al.
Published: (2013-06-01) -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
by: Melanie Joannides, et al.
Published: (2011-10-01) -
Basophils in Acute Promyelocytic Leukemia: Clonality or Reactiveness?
by: Xue Li, et al.
Published: (2025-06-01) -
PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASM
by: Richard A. Larson, et al.
Published: (2011-07-01)